Interleukin 1 alpha (IL1A) is a novel regulator of the blood-testis barrier in the rat

Biology of Reproduction

Volumn 78, Issue 3, 2008, Pages 445-454

  Sarkar, Oli ^a   Mathur, Premendu P ^b   Cheng, C Yan ^a   Mruk, Dolores D ^a  

^a POPULATION COUNCIL   (United States)

^b PONDICHERRY UNIVERSITY   (India)

Author keywords

Blood testis barrier; Cytoskeleton; Ectoplasmic specialization; Interleukin 1alpha (IL1A); Testis; Tight junction

Indexed keywords

CLAUDIN 1; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 1ALPHA; INULIN; JUNCTION ADHESION MOLECULE 1; NERVE CELL ADHESION MOLECULE; OCCLUDIN; PROTEIN; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD TESTIS BARRIER; CELL ADHESION; CELL CONTACT; CONTROLLED STUDY; GERM CELL; JUGULAR VEIN; MALE; NONHUMAN; OCCLUSAL RIDGE; PRIORITY JOURNAL; RAT; SEMINIFEROUS TUBULE EPITHELIUM; SERTOLI CELL; SPERMATOGENESIS; STEADY STATE; TARGET CELL;

ACTINS; ANIMALS; BLOOD-TESTIS BARRIER; CELL ADHESION; CELL MEMBRANE PERMEABILITY; INTERLEUKIN-1ALPHA; MALE; MODELS, BIOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; SERTOLI CELLS; SPERMATOGENESIS; SPERMATOGONIA; TIGHT JUNCTIONS; TISSUE DISTRIBUTION;

RATTUS;

EID: 40949162305     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.107.064501     Document Type: Article

References (38)

1. Russell LD. Movement of spermatocytes from the basal to the adluminal compartment of the rat testis. Am J Anat 1977; 148:313-328.
2. Mruk DD, Cheng CY. Sertoli-Sertoli and Sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. Endocr Rev 2004; 25:747-806.
3. Russell LD. Observations on the inter-relationships of Sertoli cells at the level of the blood-testis barrier: evidence for formation and resorption of Sertoli-Sertoli tubulobulbar complexes during the spermatogenic cycle of the rat. Am J Anat 1979; 155:259-279.
4. Russell LD, Peterson RN. Sertoli cell junctions: morphological and functional correlates. Int J Cytol 1985; 94:177-211.
5. Vogl AW, Pfeiffer DC, Redenbach DM, Grove BD. Sertoli cell cytoskeleton. In: Russell LD, Griswold MD (eds.), The Sertoli Cell. Clearwater, Florida: Cache River Press; 1993:39-86.
6. Wiebe JP, Barr KJ. Suppression of spermatogenesis without inhibition of steroidogenesis by 1,2,3-trihydroxypropane solution. Life Sci 1984; 34:1747-1754.
7. Setchell BP, Waites GMH. Changes in the permeability of the testicular capillaries and of the "blood-testis barrier" after injection of cadmium chloride in the rat. J Endocrinol 1970; 47:81-86.
8. Wong CH, Mruk DD, Lee WM, Cheng CY. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J 2007; 21:438-448.
9. Wiebe JP, Kowalik A, Gallardi RL, Egeler O, Clubb BH. Glycerol disrupts tight junction-associated actin microfilaments, occludin, and microtubules in Sertoli cells. J Androl 2000; 21:625-635.
10. Chung NP, Mruk D, Mo MY, Lee WM, Cheng CY. A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol Reprod 2001; 65:1340-1351.
11. Hedger MP, Meinhardt A. Cytokines and the immune-testicular axis. J Reprod Immunol 2003; 58:1-26.
12. Pollanen P, von Euler M, Soder O. Testicular immunoregulatory factors. J Reprod Immunol 1990; 18:51-76.
13. Itman C, Mendis S, Barakat B, Loveland KL. All in the family: TGF-β family action in testis development. Reproduction 2006; 132:233-246.
14. Dinarello CA. IL-1α. In: Durum SK, Hirano T, Vilcek J, Nicola NA (eds.), Cytokine Reference, vol. 1: Ligands. New York: Academic Press; 2001: 307-318.
15. Dinarello CA. IL-1β. In: Durum SK, Hirano T, Vilcek J, Nicola NA (eds.), Cytokine Reference, vol. 1: Ligands. New York: Academic Press; 2001: 351-374.
16. Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol 2002(suppl 27); 20:S1-S13.
17. Cudicini C, Lejeune H, Gomez E, Bosmans E, Ballet F, Saez J, Jegou B. Human Leydig cells and Sertoli cells are producers of interleukins-1 and -6. J Clin Endocrinol Metab 1997; 82:1426-1433.
18. Huleihel M, Lunenfeld E, Horowitz S, Levy A, Potashnik G, Glezerman M. Production of interleukin-1-like molecules by human sperm cells. Fertil Steril 2000; 73:1132-1137.
19. Calkins JH, Guo H, Sigel MM, Lin T. Differential effects of recombinant interleukin-1a and -b on Leydig cell function. Biochem Biophys Res Commun 1990; 167:548-553.
20. Syed V, Stephan JP, Gerard N, Legrand A, Parvinen M, Bardin CW, Jegou B. Residual bodies activate Sertoli cell interleukin-1α (IL-1α) release, which triggers IL-6 production by an autocrine mechanism, through the lipoxygenase pathway. Endocrinology 1995; 136:3070-3078.
21. Huleihel M, Lunenfeld E. Involvement of intratesticular IL-1 system in the regulation of Sertoli cell functions. Mol Cell Endocrinol 2002; 22:125-132.
22. Li MW, Xia W, Mruk DD, Wang CQ, Yan HH, Siu MK, Lui WY, Lee WM, Cheng CY. Tumor necrosis factor-a reversibly disrupts the blood-testis barrier and impairs Sertoli-germ cell adhesion in the seminiferous epithelium of adult rat testes. J Endocrinol 2006; 190:313-329.
23. Xia W, Mruk DD, Lee WM, Cheng CY. Differential interactions between transforming growth factor-β3/TβR1, TAB1, and CD2AP disrupt blood-testis barrier and Sertoli-germ cell adhesion. J Biol Chem 2006; 281:6799-6813.
24. Beaver BV, Reed W, Leary S, McKiernan B, Bain F, Schultz R, Bennett BT, Pascoe P, Shull E, Cork LC, Francis-Floyd R, Amass KD, et al. 2000 report of the American Veterinary Medical Association Panel in Euthanasia. J Am Vet Med Assoc 2001; 218:669-696.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-685.
27. Sarkar O, Xia W, Mruk DD. Adjudin-mediated junction restructuring in the seminiferous epithelium leads to displacement of soluble guanylate cyclase from adherens junctions. J Cell Physiol 2006; 208:175-187.
28. Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Inazawa J, Fujimoto K, Tsukita S. Mammalian occludin in epithelial cells: its expression and subcellular distribution. Eur J Cell Biol 1997; 73:222-231.
29. Xia W, Wong CH, Lee NP, Lee WM, Cheng CY. Disruption of Sertoli-germ cell adhesion function in the seminiferous epithelium of the rat testis can be limited to adherens junctions without affecting the blood-testis barrier integrity: an in vivo study using an androgen suppression model. J Cell Physiol 2005; 205:141-157.
30. O'Bryan MK, Schlatt S, Phillips DJ, de Kretser DM, Hedger MP. Bacterial lipopolysaccharide-induced inflammation compromises testicular function at multiple levels in vivo. Endocrinology 2000; 141:238-246.
31. Liew SH, Meachem SJ, Hedger MP. A stereological analysis of the response of spermatogenesis to an acute inflammatory episode in adult rats. J Androl 2007; 28:176-185.
32. Syed V, Gerard N, Kaipia A, Bardin CW, Parvinen M, Jegou B. Identification, ontogeny, and regulation of an interleukin-6-like factor in the rat seminiferous tubule. Endocrinology 1993; 132:293-299.
33. Chung SS, Mo MY, Silvestrini B, Lee WM, Cheng CY. Rat testicular N-cadherin: its complementary deoxyribonucleic acid cloning and regulation. Endocrinology 1998; 139:1853-1862.
34. Fanning AS. Organization and regulation of the tight junction by the actin-myosin cytoskeleton. In: Cereijido M, Anderson J (eds.), Tight Junctions. New York: CRC Press; 2001:265-284.
35. Stevenson BR, Begg DA. Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells. J Cell Sci 1994; 107:367-375.
36. Lu T, Tian L, Han Y, Vogelbaum M, Stark GR. Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways. Proc Natl Acad Sci U S A 2007; 104:4365-4370.
37. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-κB activation and a reciprocal suppression of TGF-β signal pathway. J Immunol 2006; 176:5598-5606.
38. Janes KA, Gaudet S, Albeck JG, Nielsen UB, Lauffenburger DA, Sorger PK. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 2006; 124:1225-1239.